Clinical effectiveness and safety of simnotrelvir/ritonavir and nirmatrelvir/ritonavir in the treatment of moderate to severe COVID-19 patients - Vienna 2024

Learning from observational studies in respiratory infection

Chair(s): Bin Cao, Anna Freeman

Session type: Poster session

Clinical effectiveness and safety of simnotrelvir/ritonavir and nirmatrelvir/ritonavir in the treatment of moderate to severe COVID-19 patients

Ji Chan Shi

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Study of impact of pneumococcal vaccine in hospitalised community acquired pneumococcal pneumonia cases: A single center experience

Shital Vishnu Patil

Poster

Abstract

Proportion of non-ventilator associated Hospital Acquired Pneumonia associated with sepsis

Laura Pilling

Poster

Abstract

Retrospective analysis of isolated respiratory pathogens spectrum and antimicrobial resistance trends: a single center ten-years follow-up

Desa Nastasijevi? Borovac

Poster

Abstract

Better post-acute sequelae COVID19 observed in hospitalized COVID19 patients treated with remdesivir

Dorottya Fesu

Poster

Abstract

Management of patients with pleural infection in Greece: initial results of the ongoing PRACTICE (PleuRAl InfeCTIon in GreeCE) study

Theofani Rimpa

Poster

Abstract

In-Hospital mortality for immunocompromised patients with SARS-CoV-2 community-acquired pneumonia (CAP)

Anna Stainer

Poster

Abstract

Characterising interferon responses in bronchiectasis patients in the EMBARC-BRIDGE study

Claire Baker

Poster

Abstract

Changes in the pulmonary surfactant in patients with mild COVID-19

Spela Kokelj

Poster

Abstract

Testing for respiratory syncytial virus (RSV) in Greek adults hospitalized with community-acquired pneumonia (CAP)

Paraskevi Katsaounou

Poster

Abstract

The association between inspiratory muscle strength and walking performance among people with post covid-19 condition; an observational study.

Ilse Maltha

Poster

Abstract

Clinical effectiveness and safety of simnotrelvir/ritonavir and nirmatrelvir/ritonavir in the treatment of moderate to severe COVID-19 patients

Ji Chan Shi

Abstract

Impact of Non-Influenza Respiratory Viruses on Emergency Department Utilization and Hospitalization

Daijiro Nabeya

Poster

Abstract

Risk Factors on Multiple Drug-Resistant Organisms Infection in Patients with Nosocomial Pneumonia and Prognosis Assessment: A National-wide, Multi-center, Large Population, Retrospective Nested Case-control Study

Zhenchao Wu

Poster

Abstract

Diagnostic yield of BAL vs. non-invasive analysis in patients with CAP

Samuel Etienne

Poster

Abstract

External validation of risk scores for the outcome of COVID-19 on a 2-year Swiss cohort A retrospective study

Maria Boesing

Poster

Abstract

Clinical characteristics and outcomes of empyema thoracis amongst patients with diabetes mellitus

Kevin Shu-leung Lai

Poster

Abstract

The impact of an acute respiratory illness virtual ward (ARIVW) on a community respiratory service

David Barber

Poster

Abstract

Inflammatory and cardiac phenotypes are predictors for complications and outcomes in hospitalized covid-19 patients

Catia Cilloniz Campos

Poster

Abstract

Infection with Staphylococcus aureus in patients with bronchiectasis: data from the EMBARC registry

Jessica Rademacher

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}